Protembis
GermanyWho owns Protembis?
Protembis is a German MedTech company, currently owned by Segulah Medical Acceleration since 2024 and 4 other investors.
Hand-verified · updated 2026-07-07
Open JSON · CC-BY
Key facts
- ·Co-held by IFB Innovationsstarter, S-UBG AG Aachen Krefeld Mönchengladbach, coparion, Segulah Medical Acceleration and XGen Venture SGR since 2015.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from XGEN Venture Life Sciences Fund
Other portfolio companies in the same fund.
Italy
UK
Sweden
More PE-backed in MedTech
Comparable medtech deals from other GPs.
USQuestions
Who owns Protembis?
Protembis is currently owned by Segulah Medical Acceleration, XGen Venture SGR and 3 others, through XGEN Venture Life Sciences Fund, since 2024.
When did Segulah Medical Acceleration and 4 others acquire Protembis?
Segulah Medical Acceleration and 4 others acquired Protembis in 2024.
Who has owned Protembis over time?
Protembis has been through 5 private-equity ownership periods: IFB Innovationsstarter · via Innovationsstarter Fonds Hamburg I · since 2015; S-UBG AG Aachen Krefeld Mönchengladbach · via Seed Fonds Aachen · since 2018; coparion · via coparion · since 2018; Segulah Medical Acceleration · via Segulah Medical Acceleration · since 2024; XGen Venture SGR · via XGEN Venture Life Sciences Fund · since 2024.